Replies to post #413419 on Anavex Life Sciences Corp (AVXL)

[RedShoulder]

Anyone in the trials getting a 30mg or 50mg daily dose of A2-73 or A3-71 for the treatment of a particular disease, they are also treating all the organs at the same time with the S1-R in homeostasis with the mitochondria.

In the present and past trials of 2-73 Blarcamesine treating either for AD, PDD, PD, or Rett , they are also potentially treating the heart, lungs, liver, kidneys, colon, eyes. etc. for some degree of improvement. Anywhere where the Mitochondria is found there will be S-1R present; which is about the entire body, with the exception of the red red blood cells that contain neither nucleus nor mitochondria and therefore does not use the oxygen it is transporting.